This is a StreetInsider.com Premium Only Page

(MRZM) – Press Releases

Oct 13, 2023 06:00 AM InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for its Flagship DuraGraft Medical Device

Oct 13, 2023 06:00 AM InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for its Flagship DuraGraft Medical Device

Oct 6, 2023 06:34 PM The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News

May 10, 2023 08:00 AM Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products

Feb 25, 2022 07:32 AM Statera Biopharma Announces Changes to Board of Directors

Jan 5, 2022 08:30 AM Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office

Dec 23, 2021 03:24 PM Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing

Dec 3, 2021 04:30 PM Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

Dec 3, 2021 10:36 AM Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

Nov 16, 2021 02:55 PM Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

Mar 31, 2021 07:33 AM Marizyme, Inc. Issues Letter to Shareholders

Mar 4, 2021 07:33 AM Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera

Feb 4, 2021 06:49 PM Marizyme, Inc. Appoints Veteran Business Executive Julie Kampf to Board

Feb 1, 2021 08:05 AM Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems

Jan 14, 2021 07:33 AM Marizyme Announces Approval for DuraGraft® in India

Jan 11, 2021 05:33 AM Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf

Jan 7, 2021 07:33 AM Marizyme, Inc. to Present at Biotech Showcase 2021 During the J.P. Morgan Healthcare Conference Biotech Showcase Digital, BIO @ JPM During "J.P. Morgan Week 2021"

Dec 4, 2020 07:33 AM Marizyme, Inc. Expands Executive Team, Board of Directors

Nov 6, 2020 07:33 AM Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors

Sep 29, 2020 04:15 PM Univest Securities, LLC. Announces Closing of Somulation, Inc. Acquisition and $7 Million Private Placement for its Client Marizyme, Inc. (OTC: MRZM)

Oct 11, 2019 04:24 PM Marizyme, Inc., Agrees to Distribute Somahlution's DuraGraft Products in South America and Mexico

Mar 28, 2019 07:30 AM Marizyme, Inc.'s MB102 Product To Initially Focus On Pediatric Stroke Market -- Spotlight Growth

Dec 14, 2018 05:00 PM Marizyme, Inc., Appoints New Members to its Board of Directors

Sep 27, 2018 12:37 AM Marizyme, Inc., Acquires Protease Drug Platform and Appoints New CEO